GHSI (Guardion Health Sciences, Inc.) Net Profit

The financial results of Guardion Health Science (GHSI) demonstrate net return dynamics, where the value of -0.01 serves as the current metric. The business relies on external capsule manufacturing plants, focusing instead on distribution and marketing. Patient trust is based on the proven efficacy of its ophthalmological supplements. Stable demand within this narrow niche is supported by the expansion of direct digital sales.

For Guardion Health Science (GHSI), net income serves as a key indicator of operational efficiency amid volatile import costs for active components. By analyzing the company's profit through GURU.Markets tools, investors track the daily difference between revenue and total expenses, allowing for an assessment of the business's ability to mitigate the logistics crisis and inflationary pressure by leveraging its pricing power.